Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OXACIL GRANULES 125MG/5ML - HSA Drug Approval Details

Approvals/HSA/OXACIL GRANULES 125MG/5ML

Approved

THERAPEUTIC

OXACIL GRANULES 125MG/5ML

DUOPHARMA (M) SDN BHD🇸🇬 Health Sciences Authority

Approval Date: Aug 5, 1998
Approval ID: 438e13d4f429d5ad
Company: DUOPHARMA (M) SDN BHD
Type: Therapeutic

Approval Details

Approval Id: 438e13d4f429d5ad
Drug Name: OXACIL GRANULES 125MG/5ML
Product Name: OXACIL GRANULES 125MG/5ML
Approval Number: SIN09934P
Approval Date: 1998-08-05
Registrant: DUOPHARMA (SINGAPORE) PTE LTD
Licence Holder: DUOPHARMA (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: GRANULE, FOR SUSPENSION
Route Of Administration: ORAL
Atc Code: J01CF02
Atc Item Name: cloxacillin
Pharma Manufacturer Name: DUOPHARMA (SINGAPORE) PTE. LTD.
Company Detail Path: /organization/duopharma-singapore-pte-ltd

Active Ingredients

CLOXACILLIN SODIUM EQV CLOXACILLIN

125 mg/5 ml

CLOXACILLIN SODIUM EQV CLOXACILLIN

125 MG/5 ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Aug 5, 1998

Approval ID

438e13d4f429d5ad

Type

Therapeutic

Back to HSA Approvals